Myasthenia gravis: Lessons from the past 10 years

Journal of Small Animal Practice

Volumn 39, Issue 8, 1998, Pages 368-372

  Shelton, G D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

CHOLINERGIC RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; IMMUNOLOGY; MYASTHENIA GRAVIS; PATHOPHYSIOLOGY; PROGNOSIS; VETERINARY MEDICINE;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; MYASTHENIA GRAVIS; PROGNOSIS; RECEPTORS, CHOLINERGIC; VETERINARY MEDICINE;

EID: 0032135744     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.1998.tb03734.x     Document Type: Article

References (32)

1. ARONSOHN, M. G., SCHUNK, K. L., CARPENTER, J. L. & KING, N. W. (1984) Clinical and pathologic features of thymoma in 15 dogs. Journal of the American Veterinary Medical Association 184, 1355-1362
2. ARSURA, E., BRUNNER, N. G., NAMBA, T. & GROB, D. (1985) High-dose intravenous methylprednisolone in myasthenia gravis. Archives in Neurology 42, 1149-1153
3. COMPSTOH, D. A. S., VINCENT, A., NEWSOM-DAVIS, J. & BATCHELOR, J. R. (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103, 579-601
4. DEWEY, C. W., BAILEY, C. S., SHELTON, G. D., KASS, P. H. & CARDINET III, G. H. (1997) Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995). Journal of Veterinary Internal Medicine 11, 50-57
5. DEWEY, C. W., SHELTON, G. D., BAILEY, C. S., WILLARD, M. D., PODELL, M. & COLLINS, R. L. (1995) Neuromuscular dysfunction in five dogs with acquired myasthenia gravis and presumptive hypothyroidism. Progress in Veterinary Neurology 6, 117-123
6. DRACHMAN, D. B. (1994) Myasthenia gravis. New England Journal of Medicine 330, 1797-1994
7. GAUTEL, M., LAKEY, A., BARLOW, D. P., HOLMES, B. A., SCALES, S., LEONARD, K., LABEIT, S., MYGLAND, A., GILHUS, N. E. & AARLI, J. A. (1993) Titan antibodies in myasthenia gravis: identification of a major immunogenic region of titan. Neurology 43, 1581-1585
8. HACKETT, T. B., VANPELT, D. R., WILLARD, M. D., MARTIN, L. G., SHELTON, G. D. & WINGFIELD, W. E. (1995) Third degree atrioventricular block associated with acquired myasthenia gravis in four dogs. Journal of the American Veterinary Medical Association 206, 1173-1176
9. HOPKINS, A. L., HOWARD, J. F., WHEELER, S. J. & KORNEGAY, J. N. (1993) Stimulated single fibre electromyography in normal dogs. Journal of Small Animal Practice 34, 271-276
10. JOHNS, T. R. (1987) Long-term corticosteroid treatment of myasthenia gravis. Annals of the New York Academy of Sciences 505, 568-583
11. JOSEPH, R. J., CARRILLO, J. M. & LENNON, V. A. (1988) Myasthenia gravis in the cat. Journal of Veterinary Internal Medicine 2, 75-79
12. KAUL, R., SHENOY, M., GOLUSZKO, E. & CHRISTADOSS, P. (1994) Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. Journal of Immunology 152, 3152-3157
13. KEESEY, J. C. (1997) A treatment algorithm for acquired myasthenia in adults. In: Proceedings: IXth International Conference on Myasthenia Gravis and Related Disorders. A New York Academy of Sciences Conference, Santa Monica, CA, May 1998. pp 753-768
14. KING, L. G. & VITE, C. H. (1998) Acute fulminating myasthenia gravis in five dogs. Journal of the American Veterinary Medical Association 212, 830-834
15. KLEBANOW, E. R. (1992) Thymoma and acquired myasthenia gravis in the dog: a case report and review of 13 additional cases. Journal of the American Animal Hospital Association 28, 63-70
16. KROTJE, L. J., Fix, A. S. & POTTHOFF, A. D. (1990) Acquired myasthenia gravis and cholangiocellular carcinoma in a dog. Journal of the American Veterinary Medical Association 197, 488-490
17. LENNON, V. A. (1997) Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenie syndrome. Neurology 48 (Suppl 5), S23-S27
18. LINDSTROM, J., SHELTON, D. & FUJII, Y. (1988) Myasthenia gravis. Advances in Immunology 42, 233-284
19. MOORE, A. S., MADEWELL, B. R., CARDINET III, G. H. & SHELTON, G. D. (1990) Osteogenic sarcoma and myasthenia gravis in a dog. Journal of the American Veterinary Medical Association 197, 226-227
20. MYGLAND, A., TYSNES, O-B., MATRE, R., VOLPE, P., AARLI, J. A. & GILHUS, N. E. (1992) Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Annals of Neurology 32, 589-591
21. OH, S. J. & CHO, H. K. (1990) Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis. Muscle and Nerve 13, 187-191
22. OH, S. J., KIM, D. E., KURUOGLU, R., BRADLEY, R. J. & DWYER, D. (1992) Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle and Nerve 15, 720-724
23. OSSERMAN, K. E. & GENKINS, G. (1971) Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mount Sinai Journal of Medicine 38, 497-537
24. ROSES, A. D., OLANOW, C. W., McADAMS, M. W. & LANE, R. J. M. (1981) No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis. Neurology 31, 220-224
25. SHELTON, G. D (1989) Canine seronegative acquired myasthenia gravis In: Proceedings, Seventh Annual Forum, American College of Veterinary Internal Medicine, San Diego. pp 999-1002
26. SHELTON, G. D. (1998) Myasthenia gravis: laboratory diagnosis and predictive factors. In: Proceedings at the 16th Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, San Diego, May 1998. pp 309-310
27. SHELTON, G. D., CARDINET III, G. H. & LINDSTROM, J. M. (1988) Canine and human myasthenia gravis autoantibodies recognize similar regions on the acetylcholine receptor. Neurology 38, 1417-1423
28. SHELTON, G. D., SCHULE, A. S. & KASS, P. H. (1997) Risk factors for acquired myasthenia gravis in dogs: 1,154 cases (1991-1995). Journal of the American Veterinary Medical Association 211, 1428-1431
29. SHELTON, G. D., WILLARD, M. D., CARDINET III, G. H. & LINDSTROM, J. (1990) Acquired myasthenia gravis: selective involvement of esophageal, pharyngeal, and facial muscles. Journal of Veterinary internal Medicine 4, 281-284
30. SKEIE, G. O., MYGLAND, G., AARU, J. A. & GILHUS, N. E. (1995) Titan antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 20, 99-104
31. VIEIRA, M. L., CAILLAT-ZUCMAN, S., GAJDOS, P., COHENKAMINSKY, S., CASTEUR, A. & BACH, J. (1993) Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. Journal of Neuroimmunology 47, 115-122
32. WILLIAMS, C. L. & LENNON, V. A. (1986) Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, α-actinin, or actin. Journal of Experimental Medicine 164, 1043-1059